Abbott, Dexcom End UPC Feud Over Glucose Monitor Patent
Abbott and Dexcom have ended their Unified Patent Court clash over blood glucose monitoring tech just a week before the court was due to weigh in, according to a document issued...To view the full article, register now.
Already a subscriber? Click here to view full article